Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era

PURPOSE: Statins have antilymphoma properties but have also been shown to inhibit the binding of rituximab to the CD20 antigen, resulting in reduced antitumor activity of rituximab in vitro. The clinical impact of statin use on the outcome of lymphoma patients treated with a rituximab-containing reg...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Nowakowski, Grzegorz S., Maurer, Matthew J., Habermann, Thomas M., Ansell, Stephen M., Macon, William R., Ristow, Kay M., Allmer, Cristine, Slager, Susan L., Witzig, Thomas E., Cerhan, James R.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2010
Fag:
Original Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815703/
https://ncbi.nlm.nih.gov/pubmed/20008638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.23.4245
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker